Cargando…
NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo
PURPOSE: Radiotherapy is one major curative treatment modality for esophageal squamous cell carcinoma (ESCC) patients. This study aimed to find out small-molecular kinase inhibitors, which can significantly enhance the radiosensitivity of ESCC in vitro and in vivo. MATERIALS AND METHODS: Ninety-thre...
Autores principales: | Hua, Yuhui, Wang, Weijia, Zheng, Xiaoli, Yang, Ling, Wu, Hongjin, Hu, Zhaoyang, Li, Ying, Yue, Jing, Jiang, Zhenzhen, Zhang, Xiaoyan, Hou, Qiang, Wu, Shixiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047839/ https://www.ncbi.nlm.nih.gov/pubmed/32158193 http://dx.doi.org/10.2147/DDDT.S203048 |
Ejemplares similares
-
NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of Leptin
por: Haissaguerre, Magalie, et al.
Publicado: (2018) -
OsBSK1-2, an Orthologous of AtBSK1, Is Involved in Rice Immunity
por: Wang, Jing, et al.
Publicado: (2017) -
Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation
por: Zhang, Hongfang, et al.
Publicado: (2015) -
The canonical Wg signaling modulates Bsk-mediated cell death in Drosophila
por: Zhang, S, et al.
Publicado: (2015) -
NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity
por: Fokas, Emmanouil, et al.
Publicado: (2012)